Industry
Roche Sells Drugs of Abuse Testing Business to Varian
In a move to divest a business whose market is not important to the company's current strategy, Roche Diagnostics has sold its worldwide nonclinical drugs of abuse testing (DAT) business to Varian, Inc. for an undisclosed amount. More...30 Nov -0001
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
New
Silver Member
Apolipoprotein A-I Assay
Apo A-I Assay
New
Newborn Screening Test
NeoMass AAAC 3.0
In Other News
DPC Granted License to Develop Cancer Diagnostics
SpectRx Regains Rights to Glucose Monitoring Technology
Savyon Diagnostics to Spin Off Nongenetic Lab Business
TriPath and AmeriPath to Develop Melanoma Assay
Alliance for Molecular Bladder Cancer Detection
Huge Growth in Asian In Vitro Diagnostic Markets
Alliance to Market HPV Test
Continued Growth Seen for MEDICA 2002
Glucose Monitoring Program Continues
Alliance to Develop Clinical Diagnostics
DakoCytomation Acquires Artisan Line from CytoLogix
Alliance for Test to Detect Early Kidney Disease
Alliance to Develop Cancer Assays
Fujirebio Acquires Rights to Ovarian Tumor Markers
Bayer to Acquire Visible Genetics, Inc.
Digene Calls Off Merger with Cytyc
Trinity Biotech to Acquire Hemostasis Business
Dako and Cytomation Announce Merger
Alliance to Develop Molecular Diagnostics
New Drug Assay Technology Licensed
Orlando to Host AACC Annual Meeting
Impac Acquires Intellidata
Alliance on Nannoarray Protein Assays
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.